COMMUNIQUÉS West-GlobeNewswire

-
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
20/08/2024 -
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
20/08/2024 -
Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung
20/08/2024 -
Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
20/08/2024 -
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
20/08/2024 -
Entera Bio to Participate in Upcoming Investor and Scientific Conferences
20/08/2024 -
Immutep Announces Late-Breaking Abstract in Head & Neck Cancer Selected for Oral Presentation at ESMO Congress 2024
20/08/2024 -
Avadel Pharmaceuticals Announces Publication in Clinical Therapeutics of Data Highlighting Weight Loss in People with Narcolepsy Treated with LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension
20/08/2024 -
Opus Genetics Receives Rare Pediatric Disease Designation from the U.S. FDA for Ocular Gene Therapy OPGx-LCA5 to Treat Rare Inherited Retinal Disease LCA5
20/08/2024 -
Incyclix Bio Appoints Dr. Andrew Beelen as Vice President of Clinical Development
20/08/2024 -
LAVA Reports Second Quarter 2024 Financial Results and Business Update
20/08/2024 -
The Joint Corp. to Participate in the 7th Annual B. Riley Securities Consumer & TMT Conference
20/08/2024 -
Infectious Disease Expert Kelly Warfield Named Sabin’s New R&D President
20/08/2024 -
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication
20/08/2024 -
Algernon Pharmaceuticals Announces Closing of Private Placement
20/08/2024 -
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/08/2024 -
Akari Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights
19/08/2024 -
Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.
19/08/2024 -
SciSparc Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI-210 Treatment
19/08/2024
Pages